US Stock MarketDetailed Quotes

SAGE Sage Therapeutics

Watchlist
  • 5.010
  • -0.020-0.40%
Trading Dec 19 10:16 ET
306.48MMarket Cap-0.90P/E (TTM)

Sage Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
337.08%11.87M
249.80%8.65M
139.89%7.9M
1,024.84%86.46M
2,621.54%77.97M
56.18%2.72M
64.82%2.47M
108.22%3.29M
21.85%7.69M
74.48%2.87M
Operating revenue
-68.96%843K
-75.61%600K
-48.69%1.69M
36.01%10.45M
-30.72%1.99M
56.18%2.72M
63.89%2.46M
108.22%3.29M
21.85%7.69M
74.48%2.87M
Cost of revenue
483.20%5.28M
586.34%1.41M
451.74%1.27M
165.56%2.16M
473.43%820K
391.85%905K
2.50%205K
-19.58%230K
47.02%813K
64.37%143K
Gross profit
264.05%6.59M
219.39%7.25M
116.48%6.63M
1,126.48%84.3M
2,734.39%77.15M
16.46%1.81M
74.40%2.27M
136.42%3.06M
19.43%6.87M
75.05%2.72M
Operating expense
-40.13%107.8M
-31.37%118.55M
-21.59%124.31M
13.88%630.76M
-23.74%119.44M
25.89%180.06M
33.13%172.73M
27.34%158.53M
18.69%553.86M
23.29%156.62M
Selling and administrative expenses
-31.89%53.22M
-25.91%55.98M
-19.99%52.57M
20.56%274.52M
-18.15%55.11M
27.10%78.14M
36.04%75.57M
41.38%65.71M
24.09%227.7M
30.49%67.33M
-General and administrative expense
-31.89%53.22M
-25.91%55.98M
-19.99%52.57M
20.56%274.52M
-18.15%55.11M
27.10%78.14M
36.04%75.57M
41.38%65.71M
24.09%227.7M
30.49%67.33M
Research and development costs
-46.45%54.58M
-35.61%62.56M
-22.72%71.73M
9.22%356.24M
-27.96%64.33M
24.97%101.92M
25.70%97.16M
18.98%92.83M
15.18%326.16M
18.36%89.3M
Operating profit
43.22%-101.2M
34.70%-111.3M
24.31%-117.68M
0.10%-546.46M
72.52%-42.29M
-25.99%-178.25M
-32.71%-170.46M
-26.19%-155.47M
-18.68%-546.99M
-22.64%-153.9M
Net non-operating interest income expense
-25.62%7.64M
-17.12%8.43M
4.24%9.2M
173.03%38.74M
39.36%9.47M
148.95%10.27M
383.97%10.17M
655.99%8.83M
392.20%14.19M
804.53%6.79M
Non-operating interest income
-25.62%7.64M
-17.12%8.43M
4.24%9.2M
173.03%38.74M
39.36%9.47M
148.95%10.27M
383.97%10.17M
655.99%8.83M
392.20%14.19M
804.53%6.79M
Other net income (expense)
100.03%9K
136.59%15K
93.62%-12K
-225,226.67%-33.77M
408.11%114K
-112,280.00%-33.65M
-191.11%-41K
-683.33%-188K
-88.81%15K
-254.17%-37K
Special income (charges)
--0
----
----
---33.39M
--213K
---33.6M
----
----
--0
--0
-Less：Restructuring and merger&acquisition
--0
----
----
--33.39M
---213K
--33.6M
----
----
--0
--0
Other non- operating income (expenses)
116.36%9K
136.59%15K
93.62%-12K
-2,653.33%-383K
-167.57%-99K
-283.33%-55K
-191.11%-41K
-683.33%-188K
-88.81%15K
-254.17%-37K
Income before tax
53.60%-93.55M
35.85%-102.85M
26.12%-108.48M
-1.63%-541.49M
77.77%-32.71M
-46.83%-201.63M
-26.94%-160.33M
-20.30%-146.83M
-16.36%-532.78M
-17.99%-147.15M
Income tax
Net income
53.60%-93.55M
35.85%-102.85M
26.12%-108.48M
-1.63%-541.49M
77.77%-32.71M
-46.83%-201.63M
-26.94%-160.33M
-20.30%-146.83M
-16.36%-532.78M
-17.99%-147.15M
Net income continuous Operations
53.60%-93.55M
35.85%-102.85M
26.12%-108.48M
-1.63%-541.49M
77.77%-32.71M
-46.83%-201.63M
-26.94%-160.33M
-20.30%-146.83M
-16.36%-532.78M
-17.99%-147.15M
Minority interest income
Net income attributable to the parent company
53.60%-93.55M
35.85%-102.85M
26.12%-108.48M
-1.63%-541.49M
77.77%-32.71M
-46.83%-201.63M
-26.98%-160.33M
-20.30%-146.83M
-16.36%-532.78M
-17.99%-147.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
53.60%-93.55M
35.85%-102.85M
26.12%-108.48M
-1.63%-541.49M
77.77%-32.71M
-46.83%-201.63M
-26.98%-160.33M
-20.30%-146.83M
-16.36%-532.78M
-17.99%-147.15M
Basic earnings per share
54.60%-1.53
36.57%-1.7
26.83%-1.8
-0.78%-9.05
78.14%-0.54
-45.89%-3.37
-25.82%-2.68
-18.84%-2.46
-15.13%-8.98
-16.51%-2.47
Diluted earnings per share
54.60%-1.53
36.57%-1.7
26.83%-1.8
-0.78%-9.05
78.14%-0.54
-45.89%-3.37
-25.82%-2.68
-18.84%-2.46
-15.13%-8.98
-16.51%-2.47
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 337.08%11.87M249.80%8.65M139.89%7.9M1,024.84%86.46M2,621.54%77.97M56.18%2.72M64.82%2.47M108.22%3.29M21.85%7.69M74.48%2.87M
Operating revenue -68.96%843K-75.61%600K-48.69%1.69M36.01%10.45M-30.72%1.99M56.18%2.72M63.89%2.46M108.22%3.29M21.85%7.69M74.48%2.87M
Cost of revenue 483.20%5.28M586.34%1.41M451.74%1.27M165.56%2.16M473.43%820K391.85%905K2.50%205K-19.58%230K47.02%813K64.37%143K
Gross profit 264.05%6.59M219.39%7.25M116.48%6.63M1,126.48%84.3M2,734.39%77.15M16.46%1.81M74.40%2.27M136.42%3.06M19.43%6.87M75.05%2.72M
Operating expense -40.13%107.8M-31.37%118.55M-21.59%124.31M13.88%630.76M-23.74%119.44M25.89%180.06M33.13%172.73M27.34%158.53M18.69%553.86M23.29%156.62M
Selling and administrative expenses -31.89%53.22M-25.91%55.98M-19.99%52.57M20.56%274.52M-18.15%55.11M27.10%78.14M36.04%75.57M41.38%65.71M24.09%227.7M30.49%67.33M
-General and administrative expense -31.89%53.22M-25.91%55.98M-19.99%52.57M20.56%274.52M-18.15%55.11M27.10%78.14M36.04%75.57M41.38%65.71M24.09%227.7M30.49%67.33M
Research and development costs -46.45%54.58M-35.61%62.56M-22.72%71.73M9.22%356.24M-27.96%64.33M24.97%101.92M25.70%97.16M18.98%92.83M15.18%326.16M18.36%89.3M
Operating profit 43.22%-101.2M34.70%-111.3M24.31%-117.68M0.10%-546.46M72.52%-42.29M-25.99%-178.25M-32.71%-170.46M-26.19%-155.47M-18.68%-546.99M-22.64%-153.9M
Net non-operating interest income expense -25.62%7.64M-17.12%8.43M4.24%9.2M173.03%38.74M39.36%9.47M148.95%10.27M383.97%10.17M655.99%8.83M392.20%14.19M804.53%6.79M
Non-operating interest income -25.62%7.64M-17.12%8.43M4.24%9.2M173.03%38.74M39.36%9.47M148.95%10.27M383.97%10.17M655.99%8.83M392.20%14.19M804.53%6.79M
Other net income (expense) 100.03%9K136.59%15K93.62%-12K-225,226.67%-33.77M408.11%114K-112,280.00%-33.65M-191.11%-41K-683.33%-188K-88.81%15K-254.17%-37K
Special income (charges) --0-----------33.39M--213K---33.6M----------0--0
-Less：Restructuring and merger&acquisition --0----------33.39M---213K--33.6M----------0--0
Other non- operating income (expenses) 116.36%9K136.59%15K93.62%-12K-2,653.33%-383K-167.57%-99K-283.33%-55K-191.11%-41K-683.33%-188K-88.81%15K-254.17%-37K
Income before tax 53.60%-93.55M35.85%-102.85M26.12%-108.48M-1.63%-541.49M77.77%-32.71M-46.83%-201.63M-26.94%-160.33M-20.30%-146.83M-16.36%-532.78M-17.99%-147.15M
Income tax
Net income 53.60%-93.55M35.85%-102.85M26.12%-108.48M-1.63%-541.49M77.77%-32.71M-46.83%-201.63M-26.94%-160.33M-20.30%-146.83M-16.36%-532.78M-17.99%-147.15M
Net income continuous Operations 53.60%-93.55M35.85%-102.85M26.12%-108.48M-1.63%-541.49M77.77%-32.71M-46.83%-201.63M-26.94%-160.33M-20.30%-146.83M-16.36%-532.78M-17.99%-147.15M
Minority interest income
Net income attributable to the parent company 53.60%-93.55M35.85%-102.85M26.12%-108.48M-1.63%-541.49M77.77%-32.71M-46.83%-201.63M-26.98%-160.33M-20.30%-146.83M-16.36%-532.78M-17.99%-147.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 53.60%-93.55M35.85%-102.85M26.12%-108.48M-1.63%-541.49M77.77%-32.71M-46.83%-201.63M-26.98%-160.33M-20.30%-146.83M-16.36%-532.78M-17.99%-147.15M
Basic earnings per share 54.60%-1.5336.57%-1.726.83%-1.8-0.78%-9.0578.14%-0.54-45.89%-3.37-25.82%-2.68-18.84%-2.46-15.13%-8.98-16.51%-2.47
Diluted earnings per share 54.60%-1.5336.57%-1.726.83%-1.8-0.78%-9.0578.14%-0.54-45.89%-3.37-25.82%-2.68-18.84%-2.46-15.13%-8.98-16.51%-2.47
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data